For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
The United States struggled with COVID-19, but some states managed to keep deaths and infections relatively low without shutting society down or ignoring the crisis.
The COVID-19 pandemic devastated the United States with over one million deaths over three years. Yet, the burden of the virus was not spread evenly across the country. States like Vermont and Washington had death rates comparable to well-performing countries in Scandinavia, while Mississippi and Arizona fared as poorly as the worst performing nations in the world, Russia and Peru. Speakers, Emma S. Castro and Joseph L. Dieleman from the Institute for Health Metrics and Evaluation, discuss the factors that contributed to those incredibly large cross-state differences in COVID-19 outcomes and the lessons learned from the parts of the United States that performed well.
China’s maintenance of the forty-eight hour pre-departure PCR testing requirement has been primarily driven by geopolitical considerations rather than public health concerns.
UK Prime Minister Rishi Sunak meets with French President Emmanuel Macron in Paris to discuss migration, trade, security, and other issues; the world enters the fourth year since the World Health Organization declared COVID-19 a global pandemic; and Academy Award-nominated films spotlight international issues.
The World Bank (and the IMF) should get credit for increasing their lending to the world's poorest countries during the pandemic. But without additional action, net flows to developing economies will fall off a cliff.
Zoonotic diseases, naturally transmissible between humans and animals, have posed a growing public health threat for decades. However, existing institutional arrangements have fallen short. The wide-ranging, large-scale, and costly effects of the COVID-19 pandemic demonstrate the value of addressing those weaknesses in global governance.
In 2023, China’s economic recovery will depend on the ability of the government to stimulate domestic consumption and on the resilience of Chinese households.
Biotechnology advances offer immense public health and consumer potential, but come with serious risks. A recent workshop held by the Council on Foreign Relations brought experts together to discuss new forms of global governance to manage those risks.
Yanzhong Huang, a senior fellow for global health at the Council and professor and director of global health studies at Seton Hall University's School of Diplomacy and International Relations, and Zongyuan Zoe Liu, a fellow for international political economy at the Council, sit down with James M. Lindsay to discuss the consequences of China’s decision to end its zero-COVID policy.
Sessions were held on the future of international cooperation, managing geopolitics and emerging health threats in the post-COVID-19 era, supply chain resilience and regional economic initiatives, preventing conflict in the Indo-Pacific, pursuing a negotiated end to the war in Ukraine, and the future of energy, climate, and geopolitics.